New Zealand's Medsafe has granted expanded provisional approval for Novavax Inc's (NASDAQ: NVAX) Nuvaxovid (NVX-CoV2373) COVID-19 vaccine in adolescents aged 12 through 17.The...
Novavax Inc (NASDAQ: NVAX) has submitted an application to the FDA for Emergency Use Authorization (EUA) for its protein-based COVID-19 vaccine as a homologous and heterologous...
Novavax, Inc. (NASDAQ: NVAX) shares are trading higher by 2.80% to $41.47, though off the session high of $43.06 after the company announced its Novaxovid COVID-19 vaccine has been...
For the consumer, inflation losing its sharp edge was the story this week. It was a move fuelled mostly by a welcomed drop in gas prices.But for the investor, the positive...
Equal-weight ETFs invest equally between all holdingsInherently value-basedCan mitigate risk as diversifies based on valueWall Street is enjoying a positive week, thanks to...
On Tuesday afternoon, the U.S. Food and Drug Administration (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted 19-2 to recommend that future booster...
Novavax, Inc., along with its wholly owned subsidiaries, Novavax AB and Novavax CZ, is a biotechnology company. The Company promotes improved health globally through the discovery, development, and commercialization of vaccines to prevent serious infectious diseases. Its recombinant technology platform harnesses the power and speed of genetic engineering to produce immunogenic nanoparticles designed to address urgent global health needs. The vaccine candidates in its near-term pipeline, including both coronavirus vaccine candidate (NVX-CoV2373) and seasonal quadrivalent influenza vaccine candidate (NanoFlu), which are genetically engineered, three-dimensional nanostructures of recombinant proteins critical to disease pathogenesis. NVX-CoV2373 is marketed under the brand name of Covovax or as Nuvaxovid COVID-19 Vaccine (SARS-CoV-2 rS [Recombinant, adjuvanted]).
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
| Technical Indicators | Buy | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
| Summary | Neutral | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 148.00 | 150.00 | 147.90 | +0.40 | +0.27% | 11.54M | London | |||
| 9.75 | 11.75 | 8.60 | +1.51 | +18.32% | 124.44M | London | |||
| 55.40 | 58.84 | 54.52 | -2.14 | -3.72% | 9.00M | London | |||
| 2.40 | 2.40 | 2.40 | 0.00 | 0.00% | 2.39M | London | |||
| 133.10 | 135.15 | 132.90 | -1.75 | -1.30% | 2.82M | London | |||
| 7.50 | 7.50 | 7.50 | -0.30 | -3.87% | 1.22M | London | |||
| 31.50 | 32.80 | 32.80 | -2.00 | -5.97% | 2.77M | London | |||
| 17.00 | 17.00 | 16.00 | +1.2500 | +7.94% | 5.57M | London | |||
| 286.00 | 286.00 | 286.00 | 0.00 | 0.00% | 0.00 | London | |||
| 262.00 | 262.00 | 262.00 | -6.50 | -2.42% | 7.72K | London | |||
| 118.62 | 119.16 | 117.44 | +1.52 | +1.30% | 7.97M | London | |||
| 2.88 | 2.88 | 2.88 | 0.00 | 0.00% | 36.63K | London | |||
| 471.10 | 472.80 | 464.20 | +7.40 | +1.60% | 2.60M | London | |||
| 888.00 | 899.20 | 875.20 | -6.00 | -0.67% | 2.29M | London | |||
| 76.00 | 77.40 | 75.95 | -1.25 | -1.62% | 1.00M | London |